47
Participants
Start Date
April 11, 2017
Primary Completion Date
September 12, 2019
Study Completion Date
October 31, 2019
MDNA55
MDNA55 is an engineered circularly permuted interleukin-4 (cpIL-4) genetically fused to the catalytic domain of the pseudomonas exotoxin A (PE).
Hospital of the University of Pennsylvania, Philadelphia
Duke University Medical Center, Durham
Boca Raton Regional Hospital, Boca Raton
Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica
University of California San Francisco, San Francisco
Oregon Health & Science University, Portland
Lead Sponsor
Medicenna Therapeutics, Inc.
INDUSTRY